fbpx

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

New article “A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling”
ChemRar Announced Successful Completion of Phase II Clinical Trials of AB5080
i2020 Accelerator Invests in Developing Novel Highly-Specific Approaches to Treatment of Neurodegenerative Diseases Based on Previously Unrecognized Protein-Protein Interactions
Read All Our News >

Pharma News

Diabetes drug has unexpected, broad implications for healthy aging
Acadia’s Nuplazid could hit blockbuster heights after strong psychosis data: analyst
Astellas inks $3B Audentes buyout to expand in gene therapy
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
Share this: